THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Issues related to antitrust and the proposed Cigna-Anthem transaction.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL CANINO KALETA | — |
| BRENDAN DEVINE | — |
| KRISTIN JULASON DAMATO | — |
| AMY ZETTLE | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate taxation; taxation of health benefits and providers of health coverage, including P.L. 111-148 (Patient Protection and Affordable Care Act). In addition, issues relating to the 40% excise tax. Issues relating to Health Savings Accounts: H.R. 4469 the Health Savings Act of 2016, S.2499, the Health Savings Act of 2016, H.R. 4832, the Health Savings Protection Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL CANINO KALETA | — |
| BRENDAN DEVINE | — |
| KRISTIN JULASON DAMATO | — |
| RICHARD P MERSKI | — |
| DAVID SCHWARTZ | — |
| AMY ZETTLE | — |
Trade (domestic/foreign) TRD
International trade agreements, specifically the Transatlantic Trade and Investment Partnership (TTIP),TransPacific Partnership (TPP), and Trade in Services Agreement (TISA), and the Bipartisan Congressional Trade Priorities and Accountability Act of 2015. US-Taiwan trade relations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD P MERSKI | — |
Health Issues HCR
Issues relating to mental health and general health and health care legislation and regulation, including P.L. 111-148 (Patient Protection and Affordable Care Act) and P.L. 111-152 (Reconciliation Act of 2010). Issues related to the health insurance excise tax, including H.R. 2050 and H.R. 879, S. 2045, the Middle Class Health Benefits Repeal Act of 2015, and S. 2075, the American Worker Health Care Tax Relief Act of 2015. Issues related to S. 1945, the Mental Health Reform Act of 2015, S. 524 the Comprehensive Addiction and Recovery Act of 2016, and S. 2680, the Mental Health Reform Act of 2016; H.R. 5046 the Comprehensive Opioid Abuse Reduction Act and H.R. 2646 the Helping Family in Mental Crisis Act of 2016. Issues relating to employer sponsored healthcare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL CANINO KALETA | — |
| BRENDAN DEVINE | — |
| KRISTIN JULASON DAMATO | — |
| DAVID SCHWARTZ | — |
| AMY ZETTLE | — |
Medicare/Medicaid MMM
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues relating to the Medicare Part D prescription drug program, various CMS demonstration programs and of P.L. 111-148 (Patient Protection and Affordable Care Act). Issues relating to Medigap insurance, and H.R. 2, The Medicare Access and CHIP Re authorization Act of 2015. Issues relating to H.R. 2579 - Securing Care for Seniors Act of 2015. Issues related to the introduction of S. 2104, A bill to amend title XVIII of the Social Security Act to provide relief to Medicare Advantage plans with a significant number of dually eligible or low-income subsidy beneficiaries and to prevent the termination of two star plans.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL CANINO KALETA | — |
| BRENDAN DEVINE | — |
| KRISTIN JULASON DAMATO | — |
| KAREN LYNN NONNEMAKER | — |
| DAVID SCHWARTZ | Chief Health Counsel, Senate Finance Committee |
| AMY ZETTLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.